Literature DB >> 24248355

Dimerization of LTβR by LTα1β2 is necessary and sufficient for signal transduction.

Jawahar Sudhamsu1, Jianping Yin, Eugene Y Chiang, Melissa A Starovasnik, Jane L Grogan, Sarah G Hymowitz.   

Abstract

Homotrimeric TNF superfamily ligands signal by inducing trimers of their cognate receptors. As a biologically active heterotrimer, Lymphotoxin(LT)α1β2 is unique in the TNF superfamily. How the three unique potential receptor-binding interfaces in LTα1β2 trigger signaling via LTβ Receptor (LTβR) resulting in lymphoid organogenesis and propagation of inflammatory signals is poorly understood. Here we show that LTα1β2 possesses two binding sites for LTβR with distinct affinities and that dimerization of LTβR by LTα1β2 is necessary and sufficient for signal transduction. The crystal structure of a complex formed by LTα1β2, LTβR, and the fab fragment of an antibody that blocks LTβR activation reveals the lower affinity receptor-binding site. Mutations targeting each potential receptor-binding site in an engineered single-chain variant of LTα1β2 reveal the high-affinity site. NF-κB reporter assays further validate that disruption of receptor interactions at either site is sufficient to prevent signaling via LTβR.

Entities:  

Keywords:  biophysics; crystallography; cytokines; mechanism

Mesh:

Substances:

Year:  2013        PMID: 24248355      PMCID: PMC3856818          DOI: 10.1073/pnas.1310838110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation.

Authors:  J Mongkolsapaya; J M Grimes; N Chen; X N Xu; D I Stuart; E Y Jones; G R Screaton
Journal:  Nat Struct Biol       Date:  1999-11

2.  Insight into Schmid metaphyseal chondrodysplasia from the crystal structure of the collagen X NC1 domain trimer.

Authors:  Oren Bogin; Marc Kvansakul; Eran Rom; Josef Singer; Avner Yayon; Erhard Hohenester
Journal:  Structure       Date:  2002-02       Impact factor: 5.006

3.  Mutations leading to X-linked hypohidrotic ectodermal dysplasia affect three major functional domains in the tumor necrosis factor family member ectodysplasin-A.

Authors:  P Schneider; S L Street; O Gaide; S Hertig; A Tardivel; J Tschopp; L Runkel; K Alevizopoulos; B M Ferguson; J Zonana
Journal:  J Biol Chem       Date:  2001-03-14       Impact factor: 5.157

Review 4.  The role of lymphotoxin in development and maintenance of secondary lymphoid tissues.

Authors:  Alexei V Tumanov; Dmitry V Kuprash; Sergei A Nedospasov
Journal:  Cytokine Growth Factor Rev       Date:  2003 Jun-Aug       Impact factor: 7.638

Review 5.  Lymphotoxin/light, lymphoid microenvironments and autoimmune disease.

Authors:  Jennifer L Gommerman; Jeffrey L Browning
Journal:  Nat Rev Immunol       Date:  2003-08       Impact factor: 53.106

6.  Aspartic acid 50 and tyrosine 108 are essential for receptor binding and cytotoxic activity of tumour necrosis factor beta (lymphotoxin).

Authors:  C R Goh; C S Loh; A G Porter
Journal:  Protein Eng       Date:  1991-10

7.  Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5.

Authors:  S G Hymowitz; H W Christinger; G Fuh; M Ultsch; M O'Connell; R F Kelley; A Ashkenazi; A M de Vos
Journal:  Mol Cell       Date:  1999-10       Impact factor: 17.970

8.  Structurally distinct recognition motifs in lymphotoxin-beta receptor and CD40 for tumor necrosis factor receptor-associated factor (TRAF)-mediated signaling.

Authors:  Chenglong Li; Paula S Norris; Chao-Zhou Ni; Marnie L Havert; Elizabeth M Chiong; Bonnie R Tran; Edelmira Cabezas; John C Reed; Arnold C Satterthwait; Carl F Ware; Kathryn R Ely
Journal:  J Biol Chem       Date:  2003-09-29       Impact factor: 5.157

9.  Structure of tumour necrosis factor.

Authors:  E Y Jones; D I Stuart; N P Walker
Journal:  Nature       Date:  1989-03-16       Impact factor: 49.962

10.  Structural basis for treating tumor necrosis factor α (TNFα)-associated diseases with the therapeutic antibody infliximab.

Authors:  Shuaiyi Liang; Jianxin Dai; Sheng Hou; Lishu Su; Dapeng Zhang; Huaizu Guo; Shi Hu; Hao Wang; Zihe Rao; Yajun Guo; Zhiyong Lou
Journal:  J Biol Chem       Date:  2013-03-15       Impact factor: 5.157

View more
  15 in total

1.  Binding Studies of TNF Receptor Superfamily (TNFRSF) Receptors on Intact Cells.

Authors:  Isabell Lang; Simone Füllsack; Agnes Wyzgol; Andrea Fick; Johannes Trebing; José Antonio Carmona Arana; Viktoria Schäfer; Daniela Weisenberger; Harald Wajant
Journal:  J Biol Chem       Date:  2015-12-31       Impact factor: 5.157

2.  Structural Basis of CD160:HVEM Recognition.

Authors:  Weifeng Liu; Sarah C Garrett; Elena V Fedorov; Udupi A Ramagopal; Scott J Garforth; Jeffrey B Bonanno; Steven C Almo
Journal:  Structure       Date:  2019-06-20       Impact factor: 5.006

Review 3.  Immune Response in Hepatitis B Virus Infection.

Authors:  Anthony Tan; Sarene Koh; Antonio Bertoletti
Journal:  Cold Spring Harb Perspect Med       Date:  2015-07-01       Impact factor: 6.915

4.  Correlating RANK ligand/RANK binding kinetics with osteoclast formation and function.

Authors:  Julia T Warren; Wei Zou; Corinne E Decker; Nidhi Rohatgi; Christopher A Nelson; Daved H Fremont; Steven L Teitelbaum
Journal:  J Cell Biochem       Date:  2015-11       Impact factor: 4.429

5.  Stoichiometry of Heteromeric BAFF and APRIL Cytokines Dictates Their Receptor Binding and Signaling Properties.

Authors:  Sonia Schuepbach-Mallepell; Dolon Das; Laure Willen; Michele Vigolo; Aubry Tardivel; Luc Lebon; Christine Kowalczyk-Quintas; Josquin Nys; Cristian Smulski; Timothy S Zheng; Klaus Maskos; Alfred Lammens; Xuliang Jiang; Henry Hess; Seng-Lai Tan; Pascal Schneider
Journal:  J Biol Chem       Date:  2015-05-07       Impact factor: 5.157

Review 6.  Mechanisms for the Invasion and Dissemination of Salmonella.

Authors:  Qiao Li
Journal:  Can J Infect Dis Med Microbiol       Date:  2022-06-09       Impact factor: 2.585

7.  A genome-scale screen for synthetic drivers of T cell proliferation.

Authors:  Mateusz Legut; Zoran Gajic; Maria Guarino; Zharko Daniloski; Jahan A Rahman; Xinhe Xue; Congyi Lu; Lu Lu; Eleni P Mimitou; Stephanie Hao; Teresa Davoli; Catherine Diefenbach; Peter Smibert; Neville E Sanjana
Journal:  Nature       Date:  2022-03-16       Impact factor: 69.504

8.  Evaluating the Use of Antibody Variable Region (Fv) Charge as a Risk Assessment Tool for Predicting Typical Cynomolgus Monkey Pharmacokinetics.

Authors:  Daniela Bumbaca Yadav; Vikas K Sharma; Charles Andrew Boswell; Isidro Hotzel; Devin Tesar; Yonglei Shang; Yong Ying; Saloumeh K Fischer; Jane L Grogan; Eugene Y Chiang; Konnie Urban; Sheila Ulufatu; Leslie A Khawli; Saileta Prabhu; Sean Joseph; Robert F Kelley
Journal:  J Biol Chem       Date:  2015-10-21       Impact factor: 5.157

9.  Repetitive ischemic injuries to the kidneys result in lymph node fibrosis and impaired healing.

Authors:  Omar H Maarouf; Mayuko Uehara; Vivek Kasinath; Zhabiz Solhjou; Naima Banouni; Baharak Bahmani; Liwei Jiang; Osman A Yilmam; Indira Guleria; Scott B Lovitch; Jane L Grogan; Paolo Fiorina; Peter T Sage; Jonathan S Bromberg; Martina M McGrath; Reza Abdi
Journal:  JCI Insight       Date:  2018-07-12

Review 10.  T cell co-stimulation and co-inhibition in cardiovascular disease: a double-edged sword.

Authors:  Karin H Simons; Alwin de Jong; J Wouter Jukema; Margreet R de Vries; Ramon Arens; Paul H A Quax
Journal:  Nat Rev Cardiol       Date:  2019-06       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.